June 2021 - Pharmaceutical Market Europe

June 2021 - Pharmaceutical Market Europe
Published on 8 June 2021

Description:

Patient diversity in clinical trials, How the AMR Action Fund is combating antimicrobial resistance, Mastering the art of communications excellence

Preview:

41 articles from this collection:
PME June 2021
PME June 2021
2 - Makara Health
2 - Makara Health
4 - Pharma Market Europe Communiqué Awards 2021
3 - Comment
3 - Comment
4 - Communiqué Awards 2021
4 - Communiqué Awards 2021
4 - PMEA 2021
4 - PMEA 2021
5 - Contents
5 - Contents
6-7 - News
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8 - News
8 - News
9 - Coronavirus news
9 - Coronavirus news
10-11 - Coronavirus news
10-11 - Coronavirus news
12 - Darwin’s medicine
12 - Darwin’s medicine
12 - Pharma Market Europe Darwin’s medicine
13 - Rohit Khanna - Policy and Public Health
13 - Rohit Khanna - Policy and Public Health
The technology responses to this pandemic have fallen far short of expectations
14 - Mike Dixon
14 - Mike Dixon
15 - Stephanie Hall
15 - Stephanie Hall
16-17 - The AMR Action Fund
16-17 - The AMR Action Fund
18-19 - Personalised medicines
18-19 - Personalised medicines
18-19 - Empowering patients empowers results
20-21 - Pharma’s authentic proof of purpose influences decisions among HCPs and payers
20-21 - Pharma’s authentic proof of purpose influences decisions among HCPs and payers
22 - Communications excellence
22 - Communications excellence
23 - Langland
23 - Langland
23 - Bedrock Healthcare Communications
23 - Bedrock Healthcare Communications
24 - Certain Health
24 - Certain Health
23 - Edelman
23 - Edelman
24 - JPA Health
24 - JPA Health
25 - Lucid Group
25 - Lucid Group
26 - Mind+Matter
26 - Mind+Matter
26 - Page & Page
26 - Page & Page
27 - Say Communications
27 - Say Communications
27 - Virgo Health
27 - Virgo Health
28-30 - The pursuit of patient diversity in clinical trials
28-30 - The pursuit of patient diversity in clinical trials
31 - ICON
31 - ICON
32-34 - Patient diversity in clinical trials needs to be centre stage
32-34 - Patient diversity in clinical trials needs to be centre stage
35 - COUCH Health
35 - COUCH Health
36 - Egality Ltd
36 - Egality Ltd
37 - Origins Insights
37 - Origins Insights
38-39 - Mastering oneself
38-39 - Mastering oneself
40-41 - Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
40-41 - Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
42-44 - Appointments
42-44 - Appointments
45 - Healthcare Comms News
45 - Healthcare Comms News
46 - Q&A with Claire Gillis
46 - Q&A with Claire Gillis
47 - Recruitment
47 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
48 - Ashfield MedComms
48 - Ashfield MedComms